Follow us
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
  • Home
    • About PMI
        About PMI
        Learn more about the people and places behind PMI's research.
        Read More
      • About PMI
      • Latest news Supported investigator initiated studies Mar 27, 2023
        Read More
      • Welcome to PMI Science
      • Our Standards
      • Our Scientists
        • PMI Postdoctoral Fellowship Program
        • Science is beautiful
        • Learnings from lockdown
      • Our Initiatives
      • Interactive tour of the Cube
      • Our Network
    • Smoke-free approach
        Smoke-free approach
        Offering smoke-free alternatives to adult smokers is a sensible, complementary addition to existing tobacco control strategies.
        Read More
      • Smoke-free approach
      • Latest news Supported investigator initiated studies Mar 27, 2023
        Read More
      • What is harm reduction?
      • Absence of combustion
      • Nicotine
      • The role of smoke-free products
      • Tar
      • Tobacco Regulation
        • EU Tobacco Products Directive
        • U.S. FDA Premarket tobacco products application
        • U.S. FDA Modified Risk Tobacco Product (MRTP) Application
    • Research
        Research
        PMI is committed to sharing results as the development and scientific assessment of smoke-free products advance.
        Read More
      • Research
      • Latest news Supported investigator initiated studies Mar 27, 2023
        Read More
      • Our Scientific Approach
        • Platform Development
        • Toxicological Assessment
        • Clinical Assessment
        • Perception and Behavior
        • Long-Term Assessment
        • How does PMI conduct its scientific assessments?
      • Our Findings
      • PMI Publications Library
      • Literature Reviews
      • Independent Studies
      • Expert Reports
      • Investigator initiated studies (IIS)
      • Latest PMI Science Booklet
      • Facts and figures on our smoke-free future
    • Our Products
        Our Products
        PMI believes that offering a range of smoke-free alternatives is essential to ensure individual smokers are able to find a smoke-free product that they can fully switch to.
        Read More
      • Our Products
      • Latest news Supported investigator initiated studies Mar 27, 2023
        Read More
      • Tobacco Heating System
      • Oven Heating System
      • MESH Vaping System
      • Disposable Vaping System
      • Oral Nicotine Pouches
      • Nicotine salts product
    • News & Events
        News & Events
        Read our most recent articles and catch up on our latest events and conference presentations.
        Read More
      • News & Events
      • Latest news Supported investigator initiated studies Mar 27, 2023
        Read More
      • Scientific Update Magazine
      • Open Science Events
      • News
      • Conferences Calendar
      • Media Library
    • Contact Us
      1. Home
      2. Research
      3. PMI Publications Library
      Posters

      Involvement Of Semiquinone Radicals Generated From Dihydroxybenzenes In The In Vitro Cytotoxicity Of Cigarette Smoke Tar

      Chouchane, S.; BMüller, BP. Müller.; Wittig, A.; Tewes, F. J.; Wooten, J. B.
      Conference date
      Nov 17, 2004
      Conference name
      11th Annual Meeting Of The Society For Free Radical Biology And Medicine
      Link to more information
      Link to more information
      Topic
      Summary

      No abstract available.

      Related Publications

      Key Challenges and Recommendations for In Vitro Testing of Tobacco Products for Regulatory Applications: Consideration of Test Materials and Exposure Parameters

      Pre-clinical Toxicology

      Quantification and mapping of alkylation in the human genome reveal single nucleotide resolution precursors of mutational signatures

      Pre-clinical Toxicology

      An in vitro evaluation of e-vapor products: The contributions of chemical adulteration, concentration, and device power

      Pre-clinical Toxicology

      Tobacco heating system has less impact on bone metabolism than cigarette smoke

      Pre-clinical Toxicology

      Novel α7 nicotinic acetylcholine receptor modulators as potential antitussive agents

      Pre-clinical Toxicology

      Differentiating the neuropharmacological properties of nicotinic acetylcholine receptor-activating alkaloids

      Pre-clinical Toxicology

      • About PMI
      • Smoke-Free Approach
      • Research
      • Our Products
      • News & Events
      • Contact Us
      • Our Standards
      • Regulatory Submissions
      • Our Initiatives
      • Glossary
      • FAQ
      • Our Network
      • Accessibility
      • Cookie Preferences
      Copyright © 2022 PMI Science
      • Privacy
      • Terms

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.